BIOMAT Database Logo BIOMAT Database Logo

Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. 1998

N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Head and Neck Cancer Research, Department of Otolaryngology, the Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.

The PTEN (MMAC1/TEP1) tumor suppressor gene was recently isolated and mapped to human chromosome band 10q23. Homozygous deletions and mutations of PTEN were observed in cell lines and sporadic cancers of the breast, kidney, and central nervous system. Germline mutations in PTEN were recently found in Cowden disease, an autosomal dominant inherited syndrome, previously mapped to chromosome bands 10q22-23. This disease is associated with a wide variety of malignancies and hamartomas of ectodermal, mesodermal, and endodermal origin. The most common neoplasms in Cowden disease patients arise in the breast, skin, and thyroid (follicular subtype). To determine the involvement of PTEN in sporadic follicular thyroid tumors, we first analyzed sporadic follicular adenomas and carcinomas for deletions of the PTEN gene. Loss of heterozygosity was found in 7/26 (27%) follicular carcinomas and 2/27 (7%) follicular adenomas, one of which was a small hemizygous deletion (approximately 3 cm). Sequence analysis of the entire PTEN coding region revealed two mutations in carcinomas with 10q loss. Our findings suggest that the PTEN tumor suppressor gene is occasionally inactivated in sporadic follicular thyroid tumors.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010744 Phosphoric Monoester Hydrolases A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. Phosphatase,Phosphatases,Phosphohydrolase,Phosphohydrolases,Phosphomonoesterase,Phosphomonoesterases,Phosphoric Monoester Hydrolase,Hydrolase, Phosphoric Monoester,Hydrolases, Phosphoric Monoester,Monoester Hydrolase, Phosphoric
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA
D051059 PTEN Phosphohydrolase A lipid phosphatase that contains a C2 DOMAIN and acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION. MMAC1 Protein,Mutated In Multiple Advanced Cancers 1 Protein,PTEN Phosphatase,PTEN Protein,PTEN Protein Phosphatase,Phosphatase and Tensin Homologue on Chromosome Ten Protein,Phosphatase, PTEN,Phosphatase, PTEN Protein,Phosphohydrolase, PTEN,Protein Phosphatase, PTEN

Related Publications

N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
November 1997, Cancer research,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas.
September 1998, The Journal of investigative dermatology,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors.
July 1999, Cancer letters,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
November 1997, Cancer research,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
May 2000, Journal of endocrinological investigation,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
February 1998, Cancer research,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
September 1994, Cancer research,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
LKB1 somatic mutations in sporadic tumors.
March 1999, The American journal of pathology,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
March 2005, Human mutation,
N Halachmi, and S Halachmi, and E Evron, and P Cairns, and K Okami, and M Saji, and W H Westra, and M A Zeiger, and J Jen, and D Sidransky
Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
September 2002, Genes, chromosomes & cancer,
Copied contents to your clipboard!